Completed PHASE2 INTERVENTIONAL 1-arm NCT02591771

Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock

Phase II Clinical Trial for a Stepwise Progression in the Treatment of Cardiogenic Shock

Sponsor: Niguarda Hospital

Interventions adrenaline

Updated 10 times since 2017 Last updated: Jul 19, 2021 Started: Oct 31, 2015 Primary completion: Jul 25, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02591771, this PHASE2 trial focuses on Cardiogenic Shock and remains completed. Sponsored by Niguarda Hospital, it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Sep 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Sep 2021 [monthly]

Completed PHASE2

▶ Show 5 earlier versions

Apr 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jun 2018 — Apr 2019 [monthly]

Recruiting PHASE2
Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE2
May 2017 — Oct 2017 [monthly]

Recruiting PHASE2
Jan 2017 — May 2017 [monthly]

Recruiting PHASE2

First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Niguarda Hospital
Ospedale San Raffaele

Data source: Niguarda Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy